Daily CSR
Daily CSR

Daily CSR

Daily news about corporate social responsibility, ethics and sustainability
Tags (3) : medical conference

Livelong Women's Health Summit 2026 Announces Speaker Lineup

Livelong Women's Health Summit 2026 Announces Speaker Lineup
07/27/2026 | Companies
Livelong Media has unveiled the complete roster of speakers and sponsors for the Livelong Women's Health Summit, taking place on September 25–26, 2026, at the Hilton Midtown in New York City. Following the overwhelming success of its sold-out debut in San Francisco, this year's event is expected to...
AI in healthcare, Bobbi Brown, brain health, CE credits, CME credits, Dr. Jessica Shepherd, Dr. Mary Claire Haver, Dr. Natalie Crawford, Dr. Sasha Hamdani, Dr. Stacy Sims, Dr. Vonda Wright, estrogen, fertility, health education, healthcare conference, healthcare innovation, healthy aging, healthy living, Hilton Midtown, hormone health, hormones, inflammation, Jane Fonda, Livelong Media, Livelong Women's Health Summit, longevity, longevity science, medical conference, medical research, menopause, mental health, midlife health, New York City, personalized medicine, preventive health, wellness summit, women's health, women's health experts, women's healthcare, women's wellness

Energenesis Biomedical Co., Ltd. to Present DFU Therapy at EWMA 2026

Energenesis Biomedical Co., Ltd. to Present DFU Therapy at EWMA 2026
04/29/2026 | Companies
Energenesis Biomedical Co., Ltd, a clinical-stage biotech company developing therapies aimed at restoring cellular energy, has announced that it will showcase clinical application data for its investigational treatment ENERGI-F703DFU at the European Wound Management Association 2026 Annual...
biopharmaceutical company, Bremen Germany, cellular energy restoration, chronic wound care, clinical case sharing, clinical-stage biotech, DFU treatment, diabetic foot ulcers, Energenesis Biomedical, ENERGI-F703DFU, European Wound Management Association, EWMA 2026, healthcare innovation, investigational drug, medical conference, regenerative medicine, topical drug, ulcer treatment, wound closure, wound healing

Jazz Pharmaceuticals Showcases Epilepsy and Narcolepsy Research at AAN 2026

Jazz Pharmaceuticals Showcases Epilepsy and Narcolepsy Research at AAN 2026
04/09/2026 | Companies
Jazz Pharmaceuticals plc announced that it will share six research abstracts—including one oral presentation—at the 2026 American Academy of Neurology (AAN) Annual Meeting, scheduled for April 18–22, 2026, in Chicago. These presentations highlight the scope of Jazz’s neuroscience work across...
AAN 2026, American Academy of Neurology, behavioral symptoms, cannabidiol, clinical research, cognitive function, Dravet syndrome, drug development, DUET study, EpiCom study, Epidiolex, epilepsy, Jazz Pharmaceuticals, Lennox-Gastaut syndrome, medical conference, narcolepsy, neurological disorders, neuroscience, patient care, Phase 3 trial, rare diseases, refractory epilepsy, sleep disorders, treatment outcomes, tuberous sclerosis complex, Xywav


Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com